Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q73539370)
Watch
English
Effect of IFNbeta and anti-IFNbeta antibodies on NK cells in multiple sclerosis patients
scientific article published on 01 June 2000
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10713368
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
title
Effect of IFNbeta and anti-IFNbeta antibodies on NK cells in multiple sclerosis patients
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10713368
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
main subject
multiple sclerosis
1 reference
based on heuristic
inferred from title
author
Antonella Facchinetti
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10713368
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
author name string
P Perini
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10713368
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
M Wadhwa
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10713368
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
M Buttarello
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10713368
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
A Meager
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10713368
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
R Thorpe
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10713368
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
G Biasi
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10713368
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
P Gallo
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10713368
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
publication date
1 June 2000
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10713368
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
published in
Journal of Neuroimmunology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10713368
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
volume
105
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10713368
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
issue
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10713368
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
page(s)
91-95
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10713368
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
cites work
A new, simple, bioassay for human IFN-gamma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900196-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacodynamics of recombinant IFN-beta during long-term treatment of malignant melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900196-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Type I interferons enhance production of IFN-gamma by NK cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900196-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural killer cells in relapsing-remitting MS: effect of treatment with interferon beta-1B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900196-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quantitation of neutralization of interferon by antibody
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900196-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immune regulation: a critical link between NK cells and CTLs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900196-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900196-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum levels of TNF, IL-6 and sCD23 correlate with changes in lymphocyte count in patients with B-cell chronic lymphocytic leukaemia receiving interferon-alpha therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900196-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controls
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900196-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New diagnostic criteria for multiple sclerosis: guidelines for research protocols
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900196-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900196-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferon--a major regulator of natural killer cell-mediated cytotoxicity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900196-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural killer cell activity in patients with multiple sclerosis given alpha interferon.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900196-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900196-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neutralizing antibodies to granulocyte-macrophage colony-stimulating factor, interleukin-1alpha and interferon-alpha but not other cytokines in human immunoglobulin preparations
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900196-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0165-5728(00)00196-X
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10713368
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
PubMed publication ID
10713368
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10713368
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713368%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit